An interventional study of Dry static apnoea and Passive rest with neutral audio in Stress, Psychological and Stress, Physiological, sponsored by Universidad Rey Juan Carlos. Not yet recruiting at 1 site in Spain. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-20.
Sponsored by Universidad Rey Juan Carlos · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 32 studies in Stress, Psychological with a site in Spain — 6 open to participants now, 8 under way, none of them phase 3. Stress, Psychological · Spain.
Among the 32 studies in Stress, Psychological with a site in Spain, this one is the 23rd largest by planned enrollment of the 25 interventional ones that give a count, is the only one that started in 2027, is one of 25 with no phase, and was the 32nd registered.
854 studies on the registry are indexed under Stress, Psychological; 141 are open to participants now.
Browse Stress, Psychological studies →6 of the 32 studies in Stress, Psychological with a site in Spain are open now. Recruiting first, the newest first:
Instituto de Investigación Marqués de Valdecilla · Sites in Spain
Ages 18+ · Healthy volunteers
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina · Sites in Spain
Ages 3–12
Universidad Villanueva · Sites in Spain
Ages 18+ · Healthy volunteers
Cardenal Herrera University · Sites in Spain
Ages 18+ · Women only · Healthy volunteers
Universitat de Lleida · Sites in Spain
Ages 18+
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 75 Stress, Psychological studies recruiting now, 34 (45%) set no upper age limit and 37 (49%) stop at 75 or younger; 14 take children under 18; 49 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
32 studies; the count open now beside each. This study's row is marked.
First in 2014; this study’s year is marked. 1 started in 2027.
This study's planned enrollment of 28 is below the median of 84 across 697 interventional studies indexed under Stress, Psychological.
Median enrollment 70 across the 25 interventional studies, 199 across the 7 observational. Of the 22 that completed or were terminated, 1 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 32 have an industry lead sponsor. The 10 most frequent:
Universidad Rey Juan Carlos is the lead sponsor of 115 studies on the registry; 25 are open to participants now.
Universidad Rey Juan Carlos has 1 study filed under Stress, Psychological — fewer than ten, so there is no comparison to draw.
3 of the studies in Stress, Psychological with a site in Spain that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07941414Rocio Dolores Prieto JuradoCompassion Cultivation Training in Intensive Care Healthcare Professionals: A Multicenter Pilot Study | 2026-12-11 |
| NCT07951294Universidad Rey Juan CarlosDry Static Apnoea for Recovery From Acute Laboratory Stress in Trained Breath-Hold Divers | 2027-04-30 |
| NCT07735832Universidad VillanuevaEmotional Regulation and Stress Coping Program for Nursing Students During Clinical Placements | 2027-07-01 |
Add all 3 to your calendar (.ics) → With an account.
Among the 32 studies in Stress, Psychological with a site in Spain, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This exploratory randomized controlled trial will test whether a short session of dry static apnoea (voluntary breath-holding while lying down, out of the water) helps trained breath-hold divers recover faster from a brief, standardized laboratory stressor than resting for the same amount of time.
Twenty-eight licensed breath-hold divers will attend a single afternoon session of about 85 minutes. All participants first complete the Maastricht Acute Stress Test (alternating immersion of one hand in cold water at about 2 °C with mental arithmetic and negative feedback). They are then randomly assigned to one of two 24-minute conditions: four supervised dry static apnoeas at 50% of their personal best (maximum 3 minutes each), or lying at rest while listening to a neutral informative audio. Both groups then rest until 60 minutes after the start of the stressor.
The main outcome is salivary cortisol 60 minutes after the start of the stressor. Heart rate, heart rate variability, blood pressure, state anxiety and perceived stress will also be compared between groups.
Background. Acute stress activates the hypothalamic-pituitary-adrenal axis, which releases cortisol, and the autonomic nervous system, which raises heart rate and reduces vagal tone. For health, how quickly these responses return to baseline matters as much as their magnitude. Slow, controlled breathing increases vagal modulation and is associated with lower anxiety. Voluntary apnoea shares conscious breathing control and additionally triggers a vagally mediated bradycardia (the diving response), which is also present in dry apnoea. Breath-hold divers often report feeling calmer after training, but this has not been tested with objective markers. To avoid the floor effect of afternoon cortisol, a standardized stressor is applied first and the trial then tests whether apnoea accelerates recovery compared with rest. Trained breath-hold divers are studied because they master the technique and do not find it aversive.
Design. Exploratory, two-arm, parallel-group randomized controlled trial with a blinded outcome assessor. Randomization in blocks of 4, stratified by sex. The outcome assessor is unaware of group allocation; the principal investigator delivers the intervention. Sessions take place in the afternoon (arrival between 15:30 and 17:00) to control for the circadian rhythm of cortisol, at the Faculty of Health Sciences, Alcorcón Campus, Universidad Rey Juan Carlos (Madrid, Spain).
Session (about 85 minutes). Baseline rest and recordings; Maastricht Acute Stress Test (5 minutes of instructions and 10 minutes alternating hand immersion in water at about 2 °C with mental arithmetic aloud and negative feedback); 24-minute intervention; rest until 60 minutes after stressor onset; final debriefing.
Interventions. Experimental group: 4 dry static apnoeas in the supine position at 50% of personal best (maximum 3 minutes), in 5-minute cycles with at least 2 minutes of free breathing between apnoeas, under continuous supervision. Hyperventilation and lung packing are not allowed. Control group: supine rest for the same duration while listening to a neutral informative audio, previously validated with the Self-Assessment Manikin.
Measurements. Four passive-drool saliva samples (S1 at -7, S2 at +22, S3 at +50 and S4 at +60 minutes relative to stressor onset), stored on ice, frozen at -20 °C and analysed in duplicate by ELISA (Demeditec DES6611). R-R intervals and ECG are recorded with a Polar H10 chest strap and analysed with Kubios HRV; blood pressure with an automatic Omron monitor; SpO2 with a finger pulse oximeter. Validated Spanish questionnaires: PSS-14, STAI-Trait, ASI-3 and MAIA-2 (online screening); STAI-6 and a visual analogue scale of stress (four times during the session); Karolinska Sleepiness Scale (end of session). Descriptive and control variables: age, sex, years of practice and personal best; menstrual cycle phase, sleep, caffeine and physical activity on the day of the session.
Statistical analysis. Cortisol will be log-transformed. Primary analysis: ANCOVA of log(S4) with group as factor and log(S1) and log(S2) as covariates. Complementary analysis: linear mixed model (group x time, S1-S4). Autonomic and subjective outcomes will be analysed in the same way, with Holm correction. Sensitivity analyses: stress responders only; adjustment for menstrual cycle phase and sex. Exploratory moderation analyses: trait anxiety, anxiety sensitivity, interoceptive awareness, chronic perceived stress and the cortisol response to the stressor. Effect sizes with 95% confidence intervals will be reported to inform the sample size of a confirmatory trial.
Sample size. As an exploratory trial, no formal power calculation is performed; following the recommendation of at least 12 participants per group for pilot studies (Julious, 2005), 28 participants (14 per group) will be enrolled to allow for losses.
Safety. Apnoeas are performed dry and lying down, which removes the risk of drowning and falls. Heart rate and SpO2 are monitored continuously and the apnoea is stopped if SpO2 falls below 85% or any symptom appears. Participants may remove the hand from the cold water at any time. A written syncope protocol is in place and a defibrillator is available at the faculty.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraception
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants complete the Maastricht Acute Stress Test and then perform a 24-minute dry static apnoea session, followed by supine rest until 60 minutes after stressor onset.
Other: Dry static apnoea · Other: Maastricht Acute Stress Test
Participants complete the Maastricht Acute Stress Test and then rest for 24 minutes listening to a neutral audio (time-matched control), followed by supine rest until 60 minutes after stressor onset.
Other: Passive rest with neutral audio · Other: Maastricht Acute Stress Test
Four dry static apnoeas in the supine position, each lasting 50% of the participant's personal best (maximum 3 minutes), in 5-minute cycles with at least 2 minutes of free breathing between apnoeas. Hyperventilation and lung packing are not allowed. Continuous supervision by an investigator trained in apnoea and first aid, with heart rate and SpO2 monitoring; the apnoea is stopped if SpO2 falls below 85% or any symptom appears.
Supine rest listening through headphones to a neutral informative audio, previously validated as emotionally neutral with the Self-Assessment Manikin. No breathing instructions are given.
Standardized laboratory stressor: 5 minutes of instructions followed by 10 minutes alternating periods of 45-90 seconds with one hand immersed in water at about 2 °C with periods of mental arithmetic aloud with negative feedback. Participants can remove the hand at any time. Debriefing at the end of the session.
Also known as: MAST
Salivary cortisol 60 minutes after stressor onset (S4)
Time frame: 60 minutes after the start of the stressor (S4), within the single experimental session; samples at 7 minutes before (S1) and 22 minutes after (S2) stressor onset are used as covariates
Salivary cortisol across the session
Time frame: 7 minutes before (S1) and 22 (S2), 50 (S3) and 60 (S4) minutes after stressor onset, within the single experimental session
Heart rate
Time frame: Baseline rest, stressor, 24-minute intervention period and recovery up to 60 minutes after stressor onset, within the single experimental session
Heart rate variability (RMSSD)
Time frame: Baseline rest, stressor, 24-minute intervention period and recovery up to 60 minutes after stressor onset, within the single experimental session
Systolic and diastolic blood pressure
Time frame: Three measurements during the single experimental session: baseline, after the stressor and at the end of the session (60 minutes after stressor onset)
State anxiety (STAI-6)
Time frame: Four time points during the single experimental session: baseline, after the stressor, after the intervention period and at the end of the session
Perceived stress (visual analogue scale)
Time frame: Four time points during the single experimental session: baseline, after the stressor, after the intervention period and at the end of the session
Minimum peripheral oxygen saturation during apnoeas (apnoea group only)
Time frame: During each of the 4 apnoeas of the 24-minute intervention period
Minimum heart rate during apnoeas (apnoea group only)
Time frame: During each of the 4 apnoeas of the 24-minute intervention period
Sleepiness (Karolinska Sleepiness Scale)
Time frame: End of the single experimental session (60 minutes after stressor onset)
Number of participants with adverse events
Time frame: From the start to the end of the single experimental session (about 85 minutes)
Start is estimated for Jan 2027; primary completion for Apr 2027, 3 months later.
Of 462 non-industry interventional studies with no phase under Stress, Psychological, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 26. This study's planned 3 months is below that.
Counting every sponsor, half of 475 studies reached it within 13 months; a quarter within 5 and three quarters within 26.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.